Siemert, J.; Wald, T.; Kolb, M.; Pettinella, I.; Böhm, U.; Pirlich, M.; Wiegand, S.; Dietz, A.; Wichmann, G.
Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers 2021, 13, 3781.
https://doi.org/10.3390/cancers13153781
AMA Style
Siemert J, Wald T, Kolb M, Pettinella I, Böhm U, Pirlich M, Wiegand S, Dietz A, Wichmann G.
Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers. 2021; 13(15):3781.
https://doi.org/10.3390/cancers13153781
Chicago/Turabian Style
Siemert, Julia, Theresa Wald, Marlen Kolb, Isolde Pettinella, Ulrike Böhm, Markus Pirlich, Susanne Wiegand, Andreas Dietz, and Gunnar Wichmann.
2021. "Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)" Cancers 13, no. 15: 3781.
https://doi.org/10.3390/cancers13153781
APA Style
Siemert, J., Wald, T., Kolb, M., Pettinella, I., Böhm, U., Pirlich, M., Wiegand, S., Dietz, A., & Wichmann, G.
(2021). Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers, 13(15), 3781.
https://doi.org/10.3390/cancers13153781